The Advanced Therapeutics in Movement & Related Disorders (ATMRD) Congress is hosted by the Parkinson & Movement Disorder (PMD) Alliance, in partnership with MedStar Georgetown University Hospital. It aims to provide discussion among clinicians of all types to enhance movement disorder clinical practices in a refreshing manner for patients, their support network, and clinicians.
The Importance of Open Communication in Patient Care: Kelly Papesh, DNP, APRN, FNP-BC
July 7th 2024The executive director of the Association of Movement Disorder Advanced Practice Providers discussed how effective patient care in movement disorders can lead to better management and treatment outcomes. [WATCH TIME: 4 minutes]
The Challenges and Innovations in Parkinson Treatment: Michael Soileau, MD, FAAN
July 6th 2024The movement disorder specialist at Texas Movement Disorder Specialists talked about the complexities and advancements in treating Parkinson disease, emphasizing the need for strategic and aggressive treatment approaches despite administrative burdens. [WATCH TIME: 5 minutes]
Cleveland Clinic's Parkinson Disease Inpatient Program Improves Patient Outcomes
June 28th 2024The Cleveland Clinic Foundation Parkinson's Inpatient Program is a proactive, multidisciplinary intervention aimed to enhance the quality and safety of care for hospitalized patients with Parkinson disease.
Advancements in Multidisciplinary Parkinson Disease Treatment: Michael Soileau, MD, FAAN
June 26th 2024The movement disorder specialist at Texas Movement Disorder Specialists talked about a comprehensive panel discussion that highlighted the evolution of Parkinson disease treatment. [WATCH TIME: 4 minutes]
Enhancing Hospital Care for Patients With Parkinson Disease: Patricia Clark, CNP
June 26th 2024The nurse practitioner at the Cleveland Clinic talked about a specialized program involving nurse practitioners that aims to improve inpatient care quality and safety for patients with Parkinson disease. [WATCH TIME: 5 minutes]
Amyloid and Non-Amyloid Advanced Therapeutics in Dementia: R. Scott Turner, PhD, MD, FANA, FAAN
June 25th 2024The director of the Memory Disorders Program at Georgetown University talked about newly approved anti-amyloid antibodies that show significant promise in slowing Alzheimer disease progression. [WATCH TIME: 5 minutes]
Disease-Modifying Therapies for Dementia in Movement Disorders: Charbel Moussa, MBBS, PhD
June 24th 2024The associate professor of neurology at Georgetown University Medical Center talked about disease-modifying therapies for movement disorder-related dementia that aim to address the underlying mechanisms of the disease. [WATCH TIME: 5 minutes]
Advanced Therapeutic Options for Parkinson Disease and Essential Tremor: Anvi Gadani, MD
Published: June 24th 2024 | Updated: July 24th 2024The assistant clinical professor of medicine at Medstar Georgetown University Hospital talked about her presentation at ATMRD where she covered various advanced therapies for managing Parkinson disease and essential tremor. [WATCH TIME: 5 minutes]
ND0612 Reduces OFF Time for Motor Fluctuations in Parkinson Disease at 12 Months
Published: June 23rd 2024 | Updated: June 24th 2024An open-label phase 2b trial assessing ND0612 showed that the rate of treatment responders increased over a 12-month period among patients with Parkinson disease who experienced motor fluctuation.
Seeking Clarity in Patient Stratification of Parkinson Disease: Mazen Elkurd, DO
August 14th 2023The director of the Movement Disorders Center at Baylor University Medical Center in Dallas, a part of Baylor Scott & White Health, talked about the dilemma of stratifying patients with Parkinson disease based on various criteria and emphasized the need for a consensus on classification. [WATCH TIME: 3 minutes]
Botulinumtoxins in the Management of Movement Disorders: Laxman Bahroo, DO
August 8th 2023The professor of neurology and residency program director at MedStar Georgetown University Hospital spoke to the evolution of the utility of botulinumtoxins in the treatment of patients with Parkinson and other movement disorders. [WATCH TIME: 4 minutes]
Addressing Patient Hesitancy in Parkinson Treatment With Education: Mazen Elkurd, DO
August 7th 2023The director of the Movement Disorders Center at Baylor University Medical Center in Dallas, a part of Baylor Scott & White Health, discussed patient reluctance towards new treatments for Parkinson disease and the role of education in defining treatment expectations for patients. [WATCH TIME: 4 minutes]
The Promise of Gene Therapies for the Management of Parkinson Disease: Mazen Elkurd, DO
August 3rd 2023The director of the Movement Disorders Center at Baylor University Medical Center in Dallas, a part of Baylor Scott & White Health, discussed the current state of treatment for Parkinson disease and gene therapy as a promising treatment for the management of the disease. [WATCH TIME: 5 minutes]
Patient-Centric, Knowledge-Driven: Advanced Therapeutics in Movement and Related Disorders™ Congress
July 14th 2023Clinicians must be armed with fact-based information on all treatment options especially newer medications and technologies—good clinical care must be both patient-centric and knowledge-driven.